Form D · Other
MedPassage, Inc.
Denver, CO · CIK 0001577994
Offering snapshot reported May 29, 2013 · SEC filing
- Reported sold
- $350K Offering amount: $350K
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2013 | Initial | $350,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-197156
Convertible Promissory Notes
Source: Form D, filed May 29, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Biselli | Director, Executive |
| Gavin Fabian | Director, Executive, Promoter |
| Christina Fabian | Director |
| Prasad Vadakkencherry Lakshminarayanan | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1062 Delaware Street
Denver, CO, 80204
Denver, CO, 80204